Anthem Biosciences Limited
ANTHEM

Anthem Biosciences Limited

Biotechnology
Share price
₹951
Market cap
₹53,602 Cr
1Y return
▲ 47%

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

Investors holding Anthem Biosciences Limited

HDFC Mutual Fund
HDFC Mutual Fund
Mutual Fund
1.90%
SBI Mutual Fund
SBI Mutual Fund
Mutual Fund
1.75%
Axis Mutual Fund
Axis Mutual Fund
Mutual Fund
1.36%

Recent moves 31

Moves31
Quant Mutual FundExited
Quant Mutual Fund is no longer listed among the major shareholders of Anthem Biosciences Limited, meaning the previous 1.47 percent stake was either entirely sold off or reduced below the 1 percent regulatory disclosure threshold.
13 Oct 2026
Read more
SBI Mutual FundDecreased
SBI Mutual Fund trimmed its stake in Anthem Biosciences from 1.76% to 1.75%, selling 50,910 shares.
13 Oct 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund reduced its stake in Anthem Biosciences Limited from 2.44% to 1.90%, selling 30,47,744 shares.
13 Oct 2026
Read more
Axis Mutual FundIncreased
Axis Mutual Fund increased its stake in Anthem Biosciences Limited from 1.19% to 1.36% by purchasing 9,79,404 shares.
13 Oct 2026
Read more
Viridity Tone LLPDecreased
Viridity Tone LLP sold 9 lakh shares of Anthem Biosciences for ₹82.67 Cr at ₹918.60 apiece in a market sale, trimming its stake from 0.18% to 0.02%.
18 Sept 2026
Read more
Manulife Investment ManagementNew position
Manulife Investment Management bought 1,95,802 shares of Anthem Biosciences Limited for ₹14.58 Cr at ₹744.80 apiece in a block deal.
18 Jun 2026
Read more
Manulife Investment ManagementNew position
Manulife Investment Management bought 14,685 shares of Anthem Biosciences Limited for ₹1.09 Cr at ₹744.80 apiece in a block deal.
18 Jun 2026
Read more
Axis Mutual FundNew position
Axis Mutual Fund newly entered Anthem Biosciences, acquiring 6,686,210 shares for a 1.19% stake.
18 Jul 2026
Read more
SBI Mutual FundIncreased
SBI Mutual Fund raised its stake in Anthem Biosciences Limited from 1.47% to 1.76%, purchasing 16,59,713 shares.
18 Jul 2026
Read more
HDFC Mutual FundIncreased
HDFC Mutual Fund increased its stake in Anthem Biosciences Limited from 2.35% to 2.44% by purchasing 5,39,413 shares.
18 Jul 2026
Read more

Track the whales in Anthem Biosciences Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1